These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 17581423)

  • 41. Malignant transformation of endometriosis and genetic alterations of K-ras and microsatellite instability.
    Amemiya S; Sekizawa A; Otsuka J; Tachikawa T; Saito H; Okai T
    Int J Gynaecol Obstet; 2004 Sep; 86(3):371-6. PubMed ID: 15325855
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alteration of the p53 tumor suppressor gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial tumors of the human ovary.
    Fujita M; Enomoto T; Inoue M; Tanizawa O; Ozaki M; Rice JM; Nomura T
    Jpn J Cancer Res; 1994 Dec; 85(12):1247-56. PubMed ID: 7852189
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Possible relevance of tumor-related genes mutation to malignant transformation of endometriosis.
    Ma X; Hui Y; Lin L; Wu Y; Zhang X; Qin X
    Eur J Gynaecol Oncol; 2016; 37(1):89-94. PubMed ID: 27048117
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Genetic analysis of endometriosis and ovarian cancer].
    Obata K; Hoshiai H
    Nihon Rinsho; 2001 Jan; 59 Suppl 1():217-20. PubMed ID: 11235170
    [No Abstract]   [Full Text] [Related]  

  • 45. Endometriosis and the development of malignant tumours of the pelvis. A review of literature.
    Van Gorp T; Amant F; Neven P; Vergote I; Moerman P
    Best Pract Res Clin Obstet Gynaecol; 2004 Apr; 18(2):349-71. PubMed ID: 15157647
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patterns of loss of heterozygosity at 10q23.3 and microsatellite instability in endometriosis, atypical endometriosis, and ovarian carcinoma arising in association with endometriosis.
    Ali-Fehmi R; Khalifeh I; Bandyopadhyay S; Lawrence WD; Silva E; Liao D; Sarkar FH; Munkarah AR
    Int J Gynecol Pathol; 2006 Jul; 25(3):223-9. PubMed ID: 16810057
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study.
    Ogawa S; Kaku T; Amada S; Kobayashi H; Hirakawa T; Ariyoshi K; Kamura T; Nakano H
    Gynecol Oncol; 2000 May; 77(2):298-304. PubMed ID: 10785482
    [TBL] [Abstract][Full Text] [Related]  

  • 48. BRCA2 alteration is important in clear cell carcinoma of the ovary.
    Goodheart MJ; Rose SL; Hattermann-Zogg M; Smith BJ; De Young BR; Buller RE
    Clin Genet; 2009 Aug; 76(2):161-7. PubMed ID: 19656163
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PIK3CA mutations in advanced ovarian carcinomas.
    Wang Y; Helland A; Holm R; Kristensen GB; Børresen-Dale AL
    Hum Mutat; 2005 Mar; 25(3):322. PubMed ID: 15712344
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian carcinoma.
    Linder A; Westbom-Fremer S; Mateoiu C; Olsson Widjaja A; Österlund T; Veerla S; Ståhlberg A; Ulfenborg B; Hedenfalk I; Sundfeldt K
    Hum Reprod; 2024 May; 39(5):1141-1154. PubMed ID: 38459814
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas.
    McConechy MK; Anglesio MS; Kalloger SE; Yang W; Senz J; Chow C; Heravi-Moussavi A; Morin GB; Mes-Masson AM; ; Carey MS; McAlpine JN; Kwon JS; Prentice LM; Boyd N; Shah SP; Gilks CB; Huntsman DG
    J Pathol; 2011 Apr; 223(5):567-73. PubMed ID: 21381030
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [An "ariditary" form of ovarian cancer].
    Birnbaum DJ; Sabatier R; Mamessier É; Birnbaum D; Bertucci F
    Med Sci (Paris); 2010 Dec; 26(12):1040-2. PubMed ID: 21187041
    [No Abstract]   [Full Text] [Related]  

  • 53. Origins and molecular pathology of ovarian cancer.
    Bell DA
    Mod Pathol; 2005 Feb; 18 Suppl 2():S19-32. PubMed ID: 15761464
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Histologic transformation of benign endometriosis to early epithelial ovarian cancer.
    Sainz de la Cuesta R; Eichhorn JH; Rice LW; Fuller AF; Nikrui N; Goff BA
    Gynecol Oncol; 1996 Feb; 60(2):238-44. PubMed ID: 8631545
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular genetic defects in endometriosis.
    Thomas EJ; Campbell IG
    Gynecol Obstet Invest; 2000; 50 Suppl 1():44-50. PubMed ID: 11093061
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular analysis of peritoneal fluid in ovarian cancer patients.
    Parrella P; Zangen R; Sidransky D; Nicol T
    Mod Pathol; 2003 Jul; 16(7):636-40. PubMed ID: 12861058
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Alterations of p53 gene in human ovarian tumor].
    Chen P; Zhang Z; Zhang Q; Wu Y
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(5):401-3. PubMed ID: 10073019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Integrating modern approaches to pathogenetic concepts of malignant transformation of endometriosis.
    Kobayashi H; Yamada Y; Kawahara N; Ogawa K; Yoshimoto C
    Oncol Rep; 2019 Mar; 41(3):1729-1738. PubMed ID: 30592289
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ovarian nongestational choriocarcinoma mixed with various epithelial malignancies in association with endometriosis.
    Hirabayashi K; Yasuda M; Osamura RY; Hirasawa T; Murakami M
    Gynecol Oncol; 2006 Jul; 102(1):111-7. PubMed ID: 16527336
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A candidate precursor to serous carcinoma that originates in the distal fallopian tube.
    Lee Y; Miron A; Drapkin R; Nucci MR; Medeiros F; Saleemuddin A; Garber J; Birch C; Mou H; Gordon RW; Cramer DW; McKeon FD; Crum CP
    J Pathol; 2007 Jan; 211(1):26-35. PubMed ID: 17117391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.